Analyst consensus rating
Health Catalyst Analyst Rating: Hold
HCAT is rated Hold by 4 analysts with a $1.83 target. As of 2026-08-27.
Direct answer
Health Catalyst's consensus rating is Hold.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $1.83.
Forecast evidence checked August 27, 2026.
Get free Health Catalyst email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.59
- Average price target
- $1.83
- High price target
- $2.00
- Low price target
- $1.50
- Low target gap
- -5.7%
- Target upside
- +14.8%
- High target gap
- +25.8%
- Target range width
- 31.4%
- Consensus rating
- Hold
- Analysts
- 4
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Health Catalyst?
Health Catalyst has a verified Hold consensus. The same dataset has an average price target of $1.83.
How far are Health Catalyst's low and high targets from the recorded price?
The low target implies -5.7%, while the high target implies +25.8%.
How many analysts are included in Health Catalyst's consensus?
The verified consensus includes 4 analysts.
How is Health Catalyst's target upside or downside calculated?
The average target of $1.83 is divided by the recorded price of $1.59, then one is subtracted to produce +14.8%. This does not guarantee a future return.
When was Health Catalyst's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.